Advertisement
Recalls
Subscribe to Recalls

The Lead

Packaging Error Prompts Recall of Naproxen Pills

October 21, 2014 11:48 am | News | Comments

A North Carolina company is recalling nearly 12,000 boxes of pain relief tablets sold at Dollar Tree stores because some cartons contain a different medication that could cause allergic reactions.         

Mylan Recalls Some Lots of Nitroglycerin Spray Used to Treat Angina

October 15, 2014 2:14 pm | by The Canadian Press | News | Comments

Some lots of the product, called Mylan-Nitro Sublingual Spray 0.4 mg Per Metered Dose, are...

Hospira Announces Voluntary Nationwide Recall of Certain Lots of Several Lifecare Products

October 15, 2014 8:44 am | News | Comments

Hospira has announced the voluntary recall of certain lots of several products in its LifeCare™...

Oregon Compounding Centers Recalls Unexpired Sterile Products Due to Lack of Sterility Assurance

October 10, 2014 8:16 am | News | Comments

The company has not received any reports of product contamination or adverse events to date, but...

View Sample

FREE Email Newsletter

Baxter Recalls One Lot of Potassium Chloride Injection

September 17, 2014 3:00 pm | News | Comments

Baxter International Inc. announced today it is voluntarily recalling one lot of Potassium Chloride Injection 10mEq per 100mL, product code 2B0826 to the hospital/pharmacy/nurse level. The recall is being initiated due to a labeling error on the shipping cartons in a single lot, which was identified by three customers.

Hospira Recalls One Lot of Heparin Sodium in 0.9% Sodium Chloride Injection

September 12, 2014 8:38 am | News | Comments

Hospira is initiating a voluntary nationwide user-level recall of one lot of Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500 mL, NDC 0409-7620-03 Lot 41-046-JT with expiration date of 01NOV 2015. This action is due to one confirmed customer report of particulate in a single unit.

Pharmacy Creations Recalls Four Product Lots Due to Potential Non-Sterility

September 8, 2014 9:56 am | News | Comments

Pharmacy Creations has voluntarily recalled four product lots (see below) following testing results conducted by Front Range, Inc., its former independent testing laboratory, that indicated that the product lots may have the potential of not being sterile.

Advertisement

Regeneca Worldwide Expands Voluntarily Recall of Regeneslim Appetite Control Capsules

September 2, 2014 9:04 am | News | Comments

Regeneca Worldwide a division of VivaCeuticals, Inc. Las Vegas, NV is expanding the voluntary nationwide recall of its RegeneSlim appetite control dietary supplement to include lot #823230415, lot #EX0616r 15813, Lot # EX0616R15814 and Lot #11414re5516 because FDA analysis confirmed the presence of DMAA.

Amgen Recalls Aranesp Prefilled Syringes in Several Countries Outside of the U.S. Due to the Presence of Visible Particulates

August 14, 2014 9:05 am | News | Comments

Amgen initiated a voluntary recall on June 26, 2014 for nine packaged lots of Aranesp (darbepoetin alfa) (500 mcg) prefilled syringes from non-U.S. distributors, wholesalers and a number of hospital pharmacies due to the potential presence of cellulose and/or polyester particles observed in a small number of syringes during a routine quality examination.

Regeneca Worldwide Recalls RegenESlim Appetite Control Capsules

August 8, 2014 8:31 am | News | Comments

Regeneca Worldwide a division of VivaCeuticals, Inc. Las Vegas, NV is conducting a voluntary nationwide recall of its RegenESlim appetite control dietary supplement from lot # EX0616R15814 and lot #11414RE5516 because FDA analysis confirmed the presence of DMAA. 

Cubist Pharmaceuticals Issues Voluntary U.S. Recall of Certain Lots of CUBICIN

August 6, 2014 8:29 am | News | Comments

Cubist Pharmaceuticals today announced it is voluntarily recalling certain lots of CUBICIN® (daptomycin for injection) to the user level due to the potential presence of glass particulate matter in vials produced by a contract manufacturer.  

BMS Issues Voluntary Nationwide Recall of COUMADIN® for Injection Due to Presence of Particulate Matter

June 30, 2014 1:40 pm | News | Comments

Bristol-Myers Squibb Company is voluntarily recalling six lots of COUMADIN® FOR INJECTION, 5 mg single-use vials in the U.S. This recall is a precautionary measure based on the company’s investigation of visible particulate matter found in a small number of COUMADIN FOR INJECTION unreleased samples.

Advertisement

Red Yeast Rice Recalled Due to Undeclared Lovastatin

June 25, 2014 8:16 am | News | Comments

Doctor’s Best is voluntarily recalling lot 3121005 (7379 bottles) of Red Yeast Rice dietary supplement, 600 mg Capsules, 120-count bottles to the retail level. Red Yeast Rice has been found to contain undeclared lovastatin, a previously approved drug indicated for the treatment of high cholesterol, making this an unapproved new drug.

Alexion Recalls Certain Lots of Soliris Due to Visible Particulate Matter

June 2, 2014 8:21 am | News | Comments

Alexion Pharmaceuticalstoday announced that it is initiating a voluntary recall of certain lots of Soliris® (eculizumab) 300 mg/30 mL concentrated solution for intravenous infusion that were manufactured using a process component during vial filling identified in the November 2013 recall to the hospital/user level.

Hospira Announces Voluntary Nationwide Recall Of One Lot Of Labetalol Hydrochloride Injection

May 19, 2014 8:52 am | News | Comments

Hospira will initiate a voluntary nationwide recall to the user level for one lot of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL) 20 mL Multidose Vial, NDC 0409-2267-20, Lot 36-225-DD, Expiration 12/01/2015. The recall is due to a confirmed customer report of embedded particulate within the glass vial and visible particles floating in the solution.

Cubist Pharmaceuticals Recalls One Lot of CUBICIN 500 mg in 10 mL Single Use Vials

April 18, 2014 2:45 pm | News | Comments

Cubist Pharmaceuticals is voluntarily recalling one lot of CUBICIN® (daptomycin for injection) to the user level due to the presence of particulate matter, reported via customer complaint and identified as glass particles, found in a single vial from this lot, produced by a contract manufacturer.

Hospira Recalls Seven Lots of Propofol Injectable Emulsion

April 18, 2014 2:36 pm | News | Comments

Hospira announced today that on April 2, 2014, it informed customers of a nationwide recall of seven lots of Propofol Injectable Emulsion, USP, to the user level due to a glass defect located on the interior neck of the vial, which was identified during a retain sample inspection where the glass vial contained visible embedded metal particulate. Free-floating metal particulates were also identified in vials upon further analysis

Advertisement

GSK Recalls Weight Loss Drug

March 28, 2014 9:11 am | by The Associated Press | News | Comments

GlaxoSmithKline is recalling the weight loss drug Alli after receiving reports of unknown pills and tablets in the bottles.                     

Shire Recalls One Batch of Gaucher Disease Drug

March 14, 2014 1:48 pm | News | Comments

Shire is recalling one batch of its Gaucher disease treatment Vpriv because particulate matter was discovered in some vials of the drug.                    

Reumofan Plus Tablets Recalled

March 13, 2014 8:34 am | News | Comments

Pain Free By Nature is recalling "Reumofan Plus" Tablets purchased through their website at www.painfreebynature.com, because they contain undeclared active pharmaceutical ingredients.           

Baxter Recalls One Lot of Peritoneal Dialysis Solution

March 6, 2014 11:13 am | News | Comments

The recall is being initiated as a result of complaints of particulate matter, identified as mold, resulting from a leak in the container.                    

Sagent Pharmaceuticals Recalls Two Lots of Zoledronic Acid Injection

March 5, 2014 8:51 am | News | Comments

Sagent Pharmaceuticals has announced the voluntary nationwide recall of two lots of Zoledronic Acid Injection due to leaking bags.                    

Med-Vet International Recalls Veterinary Insulin Syringes Due to Mismarked Syringe Barrels

February 21, 2014 8:34 am | News | Comments

Med-Vet International initiated a nationwide recall of 140 boxes of 1/2cc U-40 insulin syringes. The syringes have been found to be labeled with 40 units per 1/2cc syringe and they should be marked with only 20 units per 1/2cc, which potentially could result in lower than prescribed doses of insulin.

Mylan Recalls 10 Lots of Etomidate Injection

February 14, 2014 1:26 pm | News | Comments

Mylan has announced that its subsidiary Agila Specialties Private Limited is conducting a voluntary nationwide recall to the hospital/user level of 10 lots of Etomidate Injection 2 mg/mL - 10 mL and 20 mL.        

Merck Recalls All Supply of Combo Cholesterol Drug

January 14, 2014 1:49 pm | by LINDA A. JOHNSON, AP Business Writer | News | Comments

Merck is recalling a combination cholesterol drug, wiping out the entire U.S. stock, due to packaging defects that could reduce effectiveness. Merck says the recall covers all four dose strengths and every batch distributed since Liptruzet was launched last May.

Baxter Initiates Nationwide Voluntary Recall of Select Lots of Premix Parenteral Nutrition

January 6, 2014 8:21 am | News | Comments

Baxter International Inc. has initiated a voluntary recall in the United States of two lots of CLINIMIX and one lot of CLINIMIX E Injection parenteral nutrition products to the user level due to complaints of particulate matter found in the products

Abrams Royal Pharmacy Recalls All Lots of Unexpired Sterile Products

December 20, 2013 11:39 am | News | Comments

Abrams Royal Pharmacy is voluntarily recalling all unexpired lots of sterile products dispensed nationwide due to concerns of lack of sterility assurance. All unexpired lots of sterile compounded products are subject to the recall.  

FDA Issues Stern Warning on Medtronic Devices

November 18, 2013 8:41 am | by DAVID KOENIG, AP Business Writer | News | Comments

Federal health officials say that defects in some Medtronic devices used in heart procedures are severe enough that they could cause serious injury or death. The warning covers about 15,000 recalled guidewires, which are inserted through an artery and used to guide other devices into place, such as stents to hold open blocked arteries.

Novo Nordisk Recalls Diabetes Drugs in Europe

October 28, 2013 8:37 am | News | Comments

Novo Nordisk is recalling 3 million insulin products used for diabetes treatment in 13 European countries due to a production problem that can affect the strength of the drug. The Danish drug maker says Friday's recall affects certain batches of the prefilled insulin pen NovoMix30 FlexPen.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading